Neurology
Found 632 results
2023
Michaelson NMiriam, Watsula A, Bakare-Okpala A, Mohamadpour M, Chukwueke UN, Budhu JA.  2023.  Disparities in Neuro-Oncology.. Curr Neurol Neurosci Rep.
Zolin A, Broner SW, Yoo A, Guan I, Lakhani S, Trabilsy M, Klebanoff L, Vo M, Sarva H.  2023.  Dystonia phenomenology and treatment response in migraine.. Headache. 63(2):255-263.
Dominguez M, Minen M, Robbins MS.  2023.  Educational initiatives in headache medicine: A 20-year scoping review.. Headache.
Shetty SV, Mazzucco MR, Winokur P, Haigh SV, Rumah KRashid, Fischetti VA, Vartanian T, Linden JR.  2023.   Epsilon Toxin Binds to and Kills Primary Human Lymphocytes.. Toxins (Basel). 15(7)
Ma Y, Sannino D, Linden JR, Haigh S, Zhao B, Grigg JB, Zumbo P, Dündar F, Butler D, Profaci CP et al..  2023.  Epsilon toxin-producing Clostridium perfringens colonize the multiple sclerosis gut microbiome overcoming CNS immune privilege.. J Clin Invest. 133(9)
Homssi M, Sweeney EM, Demmon E, Mannheim W, Sakirsky M, Wang Y, Gauthier SA, Gupta A, Nguyen TD.  2023.  Evaluation of the Statistical Detection of Change Algorithm for Screening Patients with MS with New Lesion Activity on Longitudinal Brain MRI.. AJNR Am J Neuroradiol. 44(6):649-655.
Witsch J, Rutrick SB, Lansdale KN, Seitz A, Kamel H, Parikh NS, Segal AZ, Mir SA, Murthy SB, Niogi SN et al..  2023.  Influenza-Like Illness as a Short-Term Risk Factor for Arterial Dissection.. Stroke.
Tozlu C, Card S, Jamison K, Gauthier SA, Kuceyeski A.  2023.  Larger lesion volume in people with multiple sclerosis is associated with increased transition energies between brain states and decreased entropy of brain activity.. Netw Neurosci. 7(2):539-556.
Perumal J, Balabanov R, Balcer L, Galetta S, Sun Z, Li H, Rutledge D, Avila RL, Fox RJ.  2023.  Long-Term Effectiveness and Safety of Natalizumab in African American and Hispanic/Latino Patients with Early Relapsing-Remitting Multiple Sclerosis: STRIVE Data Analysis.. Neurol Ther. 12(3):833-848.
Seitz A, Parauda SC, Omran SSalehi, Schweitzer AD, Liberman AL, Murthy SB, Merkler AE, Navi BB, Iadecola C, Kamel H et al..  2023.  Long-term risk of seizure after posterior reversible encephalopathy syndrome.. Ann Clin Transl Neurol.
Simonetto M, Murthy SB.  2023.  Major Adverse Cardiovascular Events After Intracerebral Hemorrhage-It's All About Location, Location, Location.. JAMA Netw Open. 6(4):e235783.
Parikh NS, Basu E, Hwang MJi, Rosenblatt R, VanWagner LB, Lim HI, Murthy SB, Kamel H.  2023.  Management of Stroke in Patients With Chronic Liver Disease: A Practical Review.. Stroke.
Friedman SA, Robbins MS.  2023.  Millions of Migraine Attacks, Many Answers, More Questions.. Neurology.
Telesford KM, Smith C, Mettlen M, Davis MB, Cowell L, Kittles R, Vartanian T, Monson N.  2023.  Neuron-binding antibody responses are associated with Black ethnicity in multiple sclerosis during natalizumab treatment.. Brain Commun. 5(4):fcad218.
Lovibond S, Gewirtz AN, Pasquini L, Krebs S, Graham MS.  2023.  The promise of metabolic imaging in diffuse midline glioma.. Neoplasia. 39:100896.
Kaplan A, Kaleem S, Huynh M.  2023.  Quality Improvement in the Management of Subarachnoid Hemorrhage: Current State and Future Directions.. Curr Pain Headache Rep.
Simonetto M, Sheth KN, Ziai WC, Iadecola C, Zhang C, Murthy SB.  2023.  Racial and Ethnic Differences in the Risk of Ischemic Stroke After Nontraumatic Intracerebral Hemorrhage.. Stroke.
Tozlu C, Olafson E, Jamison K, Demmon E, Kaunzner U, Marcille M, Zinger N, Michaelson N, Safi N, Nguyen T et al..  2023.  The sequence of regional structural disconnectivity due to multiple sclerosis lesions.. bioRxiv.
Tozlu C, Olafson E, Jamison KW, Demmon E, Kaunzner U, Marcille M, Zinger N, Michaelson N, Safi N, Nguyen T et al..  2023.  The sequence of regional structural disconnectivity due to multiple sclerosis lesions.. Brain Commun. 5(6):fcad332.
Janocko NJ, Seitz A, Tsiouris AJ, Lappin RI, Navi BB.  2023.  Tissue-Based Thrombolysis for Wake-Up Stroke With Basilar Artery Occlusion: A Case Report.. Neurohospitalist. 13(1):86-89.
Scholtz LC, Rosenberg J, Robbins MS, Wong T, Mints G, Kaplan A, Leung D, Kamel H, Ch'ang JH.  2023.  Ultrasonography in neurology: A comprehensive analysis and review.. J Neuroimaging.
2022
Simonetto M, Rutrick S, LeMoss NM, Lansdale KN, Tagawa ST, Kamel H, Parikh N, Navi BB.  2022.  Adherence to Guideline-Recommended Cancer Screening in Stroke Survivors: A Nationwide Analysis.. J Stroke Cerebrovasc Dis. 31(3):106297.
Cho J, Nguyen TD, Huang W, Sweeney EM, Luo X, Kovanlikaya I, Zhang S, Gillen KM, Spincemaille P, Gupta A et al..  2022.  Brain oxygen extraction fraction mapping in patients with multiple sclerosis.. J Cereb Blood Flow Metab. 42(2):338-348.
Longbrake EE, Hua LH, Mowry EM, Gauthier SA, Alvarez E, Cross AH, Pei J, Priest J, Raposo C, Hafler DA et al..  2022.  The CELLO trial: Protocol of a planned phase 4 study to assess the efficacy of Ocrelizumab in patients with radiologically isolated syndrome.. Mult Scler Relat Disord. 68:104143.
Li J, Huang W, Luo X, Wen Y, Cho J, Kovanlikaya I, Gauthier SA, Nguyen TD, Spincemaille P, Wang Y.  2022.  The central vein sign in multiple sclerosis lesions: Susceptibility relaxation optimization from a routine MRI multiecho gradient echo sequence.. J Neuroimaging. 32(1):48-56.